₹13.90
(Market cap
₹2,446 Cr
Recently Viewed
Clear AllMarket cap
₹2,446 Cr
Revenue (TTM)
₹2,214 Cr
P/E Ratio
8.3
P/B Ratio
0.9
Div. Yield
0 %
Value Research Rating
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹295 Cr
ROE
5.6 %
ROCE
6.3 %
Industry P/E
34.91
EV/EBITDA
10.2
Debt to Equity
0.2
Book Value
₹383.4
EPS
₹15.7
Face value
2
Shares outstanding
70,405,751
CFO
₹-545.13 Cr
EBITDA
₹326.37 Cr
Net Profit
₹-272.53 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Unichem Lab
| -21.6 | 11.4 | -17.0 | -37.8 | 0.6 | 1.3 | 4.2 |
|
BSE Healthcare
| -2.0 | -1.9 | -2.5 | 7.6 | 24.2 | 13.4 | 10.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Unichem Lab
| -39.9 | 80.0 | 28.6 | 26.9 | -4.5 | 62.0 | -16.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Unichem Lab
|
346.3 | 2,445.5 | 2,213.9 | 294.9 | 4.2 | 4.5 | 8.3 | 0.9 |
| 357.6 | 3,247.4 | 2,521.8 | 202.5 | 9.6 | 14.3 | 16 | 2.2 | |
| 1,049.5 | 12,760.9 | 2,512.3 | 543.7 | 28.3 | 19.3 | 23.5 | 4.0 | |
| 406.9 | 7,065.3 | 1,053.1 | 293.6 | 32.3 | 24.6 | 24.1 | 5.5 | |
| 1,059.5 | 11,215.9 | 1,158.7 | 309.6 | 31.9 | 17.3 | 35.9 | 5.9 | |
| 1,614.1 | 30,478.4 | 8,850.1 | 894.8 | 15.2 | 19.8 | 35 | 6.1 | |
| 14,951.0 | 19,087.6 | 1,575.1 | 179.1 | 14.9 | 11.4 | 106.6 | 11.5 | |
| 1,884.9 | 3,125.9 | 673.7 | 202.6 | 17.6 | 19.4 | 15.4 | 5.4 | |
| 819.0 | 3,802.4 | 588.5 | 102.9 | 22.1 | 12.7 | 37.4 | 4.5 | |
| 197.5 | 5,211.1 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 7.8 |
Are these companies really bargains?
2 min read•By Danish Khanna
Top contrary bets by FIIs and DIIs
5 min read•By Rajan Gulati
2 min read•By Yash Rohra
2 min read•By Value Research
4 min read•By Anindya Bera
2 min read•By Research Desk
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology,... psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India. Read more
Incorporated
1962
Chairman
Prakash A Mody
Managing Director
Pabitrakumar Kalipada Bhattacharyya
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Unichem Laboratories Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Unichem Laboratories Ltd is ₹346.25 (NSE) and ₹346.45 (BSE) as of 10-Apr-2026 13:19 IST. Unichem Laboratories Ltd has given a return of 0.56% in the last 3 years.
The P/E ratio of Unichem Laboratories Ltd is 8.29 times as on 10-Apr-2026, a 76 discount to its peers’ median range of 34.91 times.
The P/B ratio of Unichem Laboratories Ltd is 0.91 times as on 10-Apr-2026, a 58 discount to its peers’ median range of 2.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
35.47
|
1.99
|
|
2024
|
0.00
|
1.41
|
|
2023
|
0.00
|
0.84
|
|
2022
|
55.44
|
0.70
|
|
2021
|
63.44
|
0.85
|
The 52-week high and low of Unichem Laboratories Ltd are Rs 668.00 and Rs 278.20 as of 10-Apr-2026.
Unichem Laboratories Ltd has a market capitalisation of ₹ 2,446 Cr as on 10-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Unichem Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.